Showing results (2131-2140 of 25,162) with videos related to
Sort By:
Pageof 2,517
Oncotarget|September 11, 2018
A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancerPushpinder Singh Bawa, Samathmika Ravi, Swagatika Paul, et al.Oncotarget|September 11, 2018
"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signalingCaroline Krogh Søgaard, Augun Blindheim, Lisa M Røst, et al.Oncotarget|September 11, 2018
Zac1 regulates IL-11 expression in osteoarthritisChun-Lin Kuo, Shu-Ting Liu, Yung-Lung Chang, et al.Oncotarget|August 31, 2018
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumorsKatia Corano Scheri, Erica Leonetti, Luigi Laino, et al.Oncotarget|August 31, 2018
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsyAkemi Sato, Chiho Nakashima, Tomonori Abe, et al.Oncotarget|September 1, 2018
Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patientsMarion Rapp, Stephanie Schipmann, Kira Hoffmann, et al.Oncotarget|September 1, 2018
Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cellsMichihiro Yabe, Kei Ishibashi, Akifumi Onagi, et al.Oncotarget|October 17, 2018
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancerMohamad Elbaz, Dinesh Ahirwar, Zhang Xiaoli, et al.Oncotarget|October 17, 2018
Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiformeRamon Martinez-Olivera, Angeliki Datsi, Maren Stallkamp, et al.Oncotarget|October 17, 2018
MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancerMichael J G Milevskiy, Gurveen K Sandhu, Anna Wronski, et al.Pageof 2,517